The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  TIBS -Trends in Biochemical Sciences. Regular ed

• Publication date

  2011-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.tibs.2011.03.006PMID 21531565PMCID PMC3112285
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Signalling to cancer cell invasion through PAK family kinases.

  2011cited by this paper
• Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation

  2010cited by this paper
• Protection from rapamycin-induced apoptosis by insulin-like growth factor-I is partially dependent on protein kinase C signaling.

  2010cited by this paper
• The nuts and bolts of AGC protein kinases

  2010influential reference
• Acquired resistance to BRAF inhibitors mediated by a RAF kinase switch in melanoma can be overcome by cotargeting MEK and IGF-1R/PI3K.

  2010cited by this paper
• 4E-BP1 is a key effector of the oncogenic activation of the AKT and ERK signaling pathways that integrates their function in tumors.

  2010cited by this paper
• ERK1/2 Phosphorylate Raptor to Promote Ras-dependent Activation of mTOR Complex 1 (mTORC1)*

  2010cited by this paper
• COT/MAP3K8 drives resistance to RAF inhibition through MAP kinase pathway reactivation

  2010cited by this paper
• Inhibition of mutated, activated BRAF in metastatic melanoma.

  2010cited by this paper
• Regulation of the mTOR complex 1 pathway by nutrients, growth factors, and stress.

  2010influential reference
• mTOR: from growth signal integration to cancer, diabetes and ageing

  2010influential reference
• mTOR/S6K1 and MAPK/RSK signaling pathways coordinately regulate estrogen receptor α serine 167 phosphorylation

  2010cited by this paper
• Faculty Opinions recommendation of COT drives resistance to RAF inhibition through MAP kinase pathway reactivation.

  2010cited by this paper
• Rictor is a novel target of p70 S6 kinase-1

  2010cited by this paper
• Deregulation of the PI3K and KRAS signaling pathways in human cancer cells determines their response to everolimus.

  2010cited by this paper
• RSK1 drives p27Kip1 phosphorylation at T198 to promote RhoA inhibition and increase cell motility

  2009cited by this paper
• The novel lipid raft adaptor p18 controls endosome dynamics by anchoring the MEK–ERK pathway to late endosomes

  2009cited by this paper
• Basal subtype and MAPK/ERK kinase (MEK)-phosphoinositide 3-kinase feedback signaling determine susceptibility of breast cancer cells to MEK inhibition.

  2009cited by this paper
• KSR2 is a calcineurin substrate that promotes ERK cascade activation in response to calcium signals.

  2009influential reference
• mTORC1-Activated S6K1 Phosphorylates Rictor on Threonine 1135 and Regulates mTORC2 Signaling

  2009cited by this paper
• KSR2 is an essential regulator of AMP kinase, energy expenditure, and insulin sensitivity.

  2009influential reference
• Function, regulation and pathological roles of the Gab/DOS docking proteins

  2009cited by this paper
• Regulation of mTOR Complex 1 (mTORC1) by Raptor Ser863 and Multisite Phosphorylation*

  2009cited by this paper
• p90 Ribosomal S6 Kinase and p70 Ribosomal S6 Kinase Link Phosphorylation of the Eukaryotic Chaperonin Containing TCP-1 to Growth Factor, Insulin, and Nutrient Signaling*

  2009cited by this paper
• New Insights into mTOR Signaling: mTORC2 and Beyond

  2009cited by this paper
• Characterization of Rictor Phosphorylation Sites Reveals Direct Regulation of mTOR Complex 2 by S6K1

  2009cited by this paper
• In vivo Antitumor Activity of MEK and Phosphatidylinositol 3-Kinase Inhibitors in Basal-Like Breast Cancer Models

  2009cited by this paper
• AGC kinases regulate phosphorylation and activation of eukaryotic translation initiation factor 4B

  2009cited by this paper
• Effective Use of PI3K and MEK Inhibitors to Treat Mutant K-Ras G12D and PIK3CA H1047R Murine Lung Cancers

  2008cited by this paper
• Y-box binding protein-1 serine 102 is a downstream target of p90 ribosomal S6 kinase in basal-like breast cancer cells

  2008cited by this paper
• mTOR-raptor binds and activates SGK1 to regulate p27 phosphorylation.

  2008influential reference
• Activation of PI3K/Akt and MAPK pathways regulates Myc-mediated transcription by phosphorylating and promoting the degradation of Mad1

  2008influential reference
• ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation

  2008cited by this paper
• Targeting AKT/mTOR and ERK MAPK signaling inhibits hormone-refractory prostate cancer in a preclinical mouse model.

  2008cited by this paper
• Filamin A is a novel caveolin-1-dependent target in IGF-I-stimulated cancer cell migration.

  2008cited by this paper
• Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancer.

  2008cited by this paper
• The RSK family of kinases: emerging roles in cellular signalling

  2008cited by this paper
• Akt3 and mutant V600E B-Raf cooperate to promote early melanoma development.

  2008cited by this paper
• Ran-binding protein 3 phosphorylation links the Ras and PI3-kinase pathways to nucleocytoplasmic transport.

  2008cited by this paper
• MAP kinase signalling pathways in cancer

  2007cited by this paper
• The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition

  2007cited by this paper
• Mitogenic signaling pathways induced by G protein‐coupled receptors

  2007cited by this paper
• Integrating signals from RTKs to ERK/MAPK

  2007influential reference
• RAS/ERK Signaling Promotes Site-specific Ribosomal Protein S6 Phosphorylation via RSK and Stimulates Cap-dependent Translation*

  2007cited by this paper
• AKT/PKB signaling: navigating downstream.

  2007cited by this paper
• Regulation of multisite phosphorylation and 14-3-3 binding of AS160 in response to IGF-1, EGF, PMA and AICAR.

  2007influential reference
• Evidence That Ser87 of BimEL Is Phosphorylated by Akt and Regulates BimEL Apoptotic Function*

  2006cited by this paper
• Ribosomal protein S6 phosphorylation: from protein synthesis to cell size.

  2006cited by this paper
• Akt-Mediated YB-1 Phosphorylation Activates Translation of Silent mRNA Species

  2006cited by this paper
• Peptide growth factors signal differentially through protein kinase C to extracellular signal-regulated kinases in neonatal cardiomyocytes.

  2006cited by this paper
• Erk associates with and primes GSK-3beta for its inactivation resulting in upregulation of beta-catenin.

  2005cited by this paper
• Erk Associates with and Primes GSK-3β for Its Inactivation Resulting in Upregulation of β-Catenin

  2005cited by this paper
• FOXO transcription factors at the interface between longevity and tumor suppression

  2005cited by this paper
• Akt phosphorylates the Y-box binding protein 1 at Ser102 located in the cold shock domain and affects the anchorage-independent growth of breast cancer cells

  2005cited by this paper
• The BAD protein integrates survival signaling by EGFR/MAPK and PI3K/Akt kinase pathways in PTEN-deficient tumor cells.

  2005cited by this paper
• Phosphorylation of p27Kip1 at Thr-157 Interferes with Its Association with Importin α during G1 and Prevents Nuclear Re-entry*

  2005influential reference
• mTOR and S6K1 mediate assembly of the translation preinitiation complex through dynamic protein interchange and ordered phosphorylation events.

  2005cited by this paper
• p27Kip1 modulates cell migration through the regulation of RhoA activation.

  2004cited by this paper
• Tumor-promoting phorbol esters and activated Ras inactivate the tuberous sclerosis tumor suppressor complex via p90 ribosomal S6 kinase.

  2004influential reference
• Identification of major ERK-related phosphorylation sites in Gab1.

  2004cited by this paper
• A rapid method for determining protein kinase phosphorylation specificity

  2004cited by this paper
• Ribosomal S6 Kinase (RSK) Regulates Phosphorylation of Filamin A on an Important Regulatory Site

  2004cited by this paper
• Phosphorylation of p27Kip1 at Threonine 198 by p90 Ribosomal Protein S6 Kinases Promotes Its Binding to 14-3-3 and Cytoplasmic Localization*

  2003cited by this paper
• Protein Kinase A Blocks Raf-1 Activity by Stimulating 14-3-3 Binding and Blocking Raf-1 Interaction with Ras*

  2003cited by this paper
• Activation of phosphoinositide 3-kinase gamma by Ras.

  2002cited by this paper
• Akt-dependent Phosphorylation of p27Kip1Promotes Binding to 14-3-3 and Cytoplasmic Localization*

  2002influential reference
• Faculty Opinions recommendation of Activation of phosphoinositide 3-kinase gamma by Ras.

  2002cited by this paper
• Regulation of Raf-Akt Cross-talk

  2002cited by this paper
• Cyclic AMP-Dependent Kinase Regulates Raf-1 Kinase Mainly by Phosphorylation of Serine 259

  2002cited by this paper
• Activation of Phosphoinositide 3-Kinase γ by Ras

  2002cited by this paper
• Filamin is essential in actin cytoskeletal assembly mediated by p21-activated kinase 1

  2002cited by this paper
• ERK Negatively Regulates the Epidermal Growth Factor-mediated Interaction of Gab1 and the Phosphatidylinositol 3-Kinase*

  2002cited by this paper
• Regulation of Raf‐1 activation and signalling by dephosphorylation

  2002cited by this paper
• A Method to Identify Serine Kinase Substrates

  2002influential reference
• The Extracellular Signal-regulated Kinase Pathway Regulates the Phosphorylation of 4E-BP1 at Multiple Sites*

  2002cited by this paper
• Receptor-Specific Regulation of Phosphatidylinositol 3′-Kinase Activation by the Protein Tyrosine Phosphatase Shp2

  2002cited by this paper
• Phosphatidylinositol-3-OH Kinase (PI3K)/AKT2, activated in breast cancer, regulates and is induced by estrogen receptor alpha (ERalpha) via interaction between ERalpha and PI3K.

  2001cited by this paper
• Crystal Structure of Glycogen Synthase Kinase 3β: Structural Basis for Phosphate-Primed Substrate Specificity and Autoinhibition

  2001cited by this paper
• Crystal structure of glycogen synthase kinase 3 beta: structural basis for phosphate-primed substrate specificity and autoinhibition.

  2001cited by this paper
• PTEN inhibits insulin-stimulated MEK/MAPK activation and cell growth by blocking IRS-1 phosphorylation and IRS-1/Grb-2/Sos complex formation in a breast cancer model.

  2001cited by this paper
• p70S6 kinase signals cell survival as well as growth, inactivating the pro-apoptotic molecule BAD

  2001cited by this paper
• Negative regulation of the serine/threonine kinase B-Raf by Akt.

  2000cited by this paper
• Cell signaling by receptor tyrosine kinases.

  2000cited by this paper
• Differential Regulation of Glycogen Synthase Kinase 3β by Insulin and Wnt Signaling*

  2000cited by this paper
• Cell signaling by receptor tyrosine kinases.

  2000cited by this paper
• Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability.

  2000cited by this paper
• Phosphorylation and inactivation of glycogen synthase kinase 3 by protein kinase A.

  2000cited by this paper
• Rsk1 mediates a MEK-MAP kinase cell survival signal.

  2000cited by this paper
• p90RSK Blocks Bad-mediated Cell Death via a Protein Kinase C-dependent Pathway*

  1999cited by this paper
• Phosphorylation of the Transcription Factor Forkhead Family Member FKHR by Protein Kinase B*

  1999cited by this paper
• Protein kinase B/Akt-mediated phosphorylation promotes nuclear exclusion of the winged helix transcription factor FKHR1.

  1999cited by this paper
• Phosphorylation and inactivation of BAD by mitochondria-anchored protein kinase A.

  1999cited by this paper
• Role of protein kinase B and the MAP kinase cascade in mediating the EGF-dependent inhibition of glycogen synthase kinase 3 in Swiss 3T3 cells.

  1999cited by this paper
• Role of protein kinase B and the MAP kinase cascade in mediating the EGF‐dependent inhibition of glycogen synthase kinase 3 in Swiss 3T3 cells 1

  1999cited by this paper
• Negative Regulation of the Forkhead Transcription Factor FKHR by Akt*

  1999cited by this paper
• Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms.

  1999cited by this paper
• Phosphorylation and regulation of Raf by Akt (protein kinase B).

  1999cited by this paper
• pp90rsk1 Regulates Estrogen Receptor-Mediated Transcription through Phosphorylation of Ser-167

  1998cited by this paper
• Determination of the Specific Substrate Sequence Motifs of Protein Kinase C Isozymes*

  1997cited by this paper
• The 70 kDa S6 kinase complexes with and is activated by the Rho family G proteins Cdc42 and Rac1.

  1996cited by this paper

• Botulinum Neurotoxin Type A1 Alleviates Bleomycin-induced Skin Fibrosis by Inhibiting PI3K-Akt Pathway and Associated Cell Cycle and Proliferation.

  2026cites this paper
• Amelogenin promotes cellular activation of stem cells derived from human exfoliated deciduous teeth through CD63-mediated ERK1/2 phosphorylation

  2026cites this paper
• Api5-FGF2 regulates the transformation of breast epithelial cells via PDK1/Akt and Ras/MAPK/ERK signalling

  2026cites this paper
• KRAS Inhibition in Pancreatic Ductal Adenocarcinoma

  2026cites this paper
• Aberrant sialylation in cancer: From molecular mechanisms to potential therapeutics

  2026cites this paper
• Cellular plasticity: a double-edged sword driving malignant transformation and adaptive remodeling in stem cells

  2026cites this paper
• T-cadherin, a major adiponectin binding partner, suppresses ERK signaling in metabolic tissues.

  2026cites this paper
• Upregulation of mitoNEET disrupts granulosa cell proliferation, apoptosis and mitochondrial homeostasis : a possible pathogenesis of follicular dysplasia in PCOS.

  2026cites this paper
• Long-Term Disease-Free Survival After Sorafenib-Combined Chemotherapy for Refractory Metastatic Testicular Germ Cell Tumor: A Five-Year Follow-Up

  2026cites this paper
• Exploring the inherent susceptibility of cancer-associated fibroblasts to oncolytic virus infection

  2026cites this paper
• AI-Guided Discovery of Oncogenic Signaling Crosstalk in Tumor Progression and Drug Resistance

  2026cites this paper
• A Hidden “Promoter”: Schistosoma japonicum soluble egg antigen activates MAPK/PI3K-AKT pathways and inhibits autophagy to facilitate colorectal cancer

  2026cites this paper
• The Role of Saponin and its Nanoparticles on Malate Dehydrogenase Activity against Liver Cancer.

  2026cites this paper
• Keratin as a Potential Prognostic Biomarker for Breast Cancer Progression: An Evidence-Synthesizing Narrative Review

  2026cites this paper
• Advances and Therapeutic Potential of Anthraquinone Compounds in Neurodegenerative Diseases: A Comprehensive Review

  2026cites this paper
• Gastrodin inhibits the formation of ataxin-3 aggregates by regulating the level of ERK1/2/P38 proteins

  2026cites this paper
• Metabolic and behavioral effects of neurofibromin result from differential recruitment of MAPK and mTOR signaling.

  2026cites this paper
• Unveiling urethral cellular heterogeneity in menopause through single-nucleus RNA sequencing

  2026cites this paper
• Modulation of Network Plasticity Opens Novel Therapeutic Possibilities in Cancer, Diabetes, and Neurodegeneration

  2026cites this paper
• Innovative Strategies in Oral Carcinoma: Disrupting Cell Signaling for Therapeutic Advances.

  2026cites this paper
• Neuroprotective Activities of Nigella sativa Ethanolic Extract and Telmisartan Against Fipronil-Induced Neurotoxicity in Rats via Regulation of Apoptosis, Endosomal Micro-autophagy, and miRNA-137-5p.

  2026cites this paper
• Clinical management and therapeutic development for the rare disease rhabdomyosarcoma

  2026cites this paper
• Development of a severe rat refeeding syndrome model and mathematical modeling of the associated hypophosphatemia.

  2026cites this paper
• Pan-RAF inhibitor exarafenib targets BRAF class II/III NSCLC and reveals ARAF-KSR1 resistance and combination strategies.

  2026cites this paper
• Phosphoproteomics Identification of ERK-Dependent Activation of Rps6kb1 in Cardiac Hypertrophy.

  2026cites this paper
• Oral Microbiota and Carcinogenesis: Exploring the Systemic Impact of Oral Pathogens

  2025cites this paper
• A painless nerve growth factor variant uncouples nociceptive and neurotrophic TrkA signaling

  2025cites this paper
• ERK builds a population of short-lived nascent adhesions that produce persistent edge protrusion and cell migration

  2025cites this paper
• Active Fraction of Tillandsia usneoides Induces Structural Neuroplasticity in Cortical Neuron Cultures from Wistar Rats

  2025cites this paper
• A Multikinase Inhibitor AX-0085 Blocks FGFR1 Activation to Overcomes Osimertinib Resistance in Non-Small Cell Lung Cancer

  2025cites this paper
• Targeting BRAF Class II and III Mutations in NSCLC with the pan-RAF inhibitor Exarafenib Reveals ARAF-KSR1-Mediated Resistance and Rational Combination Strategies

  2025cites this paper
• The CTLH ubiquitin ligase substrates ZMYND19 and MKLN1 negatively regulate mTORC1 at the lysosomal membrane

  2025cites this paper
• The MTORC1 signaling pathway related gene POLR3G serves as a potential prognostic biomarker in Hepatocellular Carcinoma

  2025cites this paper
• Potential signaling pathways, biomarkers, natural drugs, and chronic myeloid leukemia therapeutics

  2025cites this paper
• Cell Type‐Specific mTORC1 Signaling and Translational Control in Synaptic Plasticity and Memory

  2025cites this paper
• Natural Products Targeting the EGFR/HER2 Axis in Tumorigenesis: Interpretation of Molecular Mechanisms and Recent Insights Into Synergistic Strategies for Cancer Therapy

  2025cites this paper
• Drugging the undruggable: Chemical and biological insights into molecular glues in the pipeline.

  2025cites this paper
• DGKα inhibition enhances the antitumor effect of chiauranib on transformed follicular lymphoma

  2025cites this paper
• Receptor-mediated nose-to-brain delivery of drug combination-loaded polymeric nanocarriers for the treatment of glioblastoma- current progress and future perspectives part I: receptor-mediated nose-to-brain delivery approaches for glioblastoma

  2025cites this paper
• AKT as a Therapeutic Target in Cancer.

  2025cites this paper
• Renal Coenzyme A (CoA) Production Fuels Stem Cell Proliferation and Tumor Growth

  2025cites this paper
• Molecular Mechanisms of Radiation Resistance in Breast Cancer: A Systematic Review of Radiosensitization Strategies

  2025cites this paper
• HER3 in breast cancer: molecular insights, clinical implications, and therapeutic horizons

  2025cites this paper
• CIAPIN1 promotes survival, proliferation, migration and glycolysis of endometrial cancer cells through PI3K/Akt pathway

  2025cites this paper
• Metabolic and behavioral effects of neurofibromin result from differential recruitment of MAPK and mTOR signaling

  2025cites this paper
• Suppression of Sebum Production by Vemurafenib Through Paradoxical ERK Activation Resulted in the Inhibition of the mTOR Pathway in 5α‐Dihydrotestosterone‐Differentiated Hamster Sebocytes In Vitro

  2025cites this paper
• Cells prioritize the regulation of cell mass density.

  2025cites this paper
• FRA1 (FOSL1) suppresses neoplastic transformation and modulates radiation responses via transcriptional control of mitogenic and stress-responsive networks

  2025cites this paper
• Epigenetic and Transcriptional Programs Define Osteosarcoma Subtypes and Establish Targetable Vulnerabilities

  2025cites this paper
• Lung microbiome dynamics in health and lung cancer

  2025cites this paper
• Restoration of Spermatogenesis is Dependent on Activation of a SPRY4-ERK Checkpoint Following Germline Stem Cell Damage

  2025influential citation
• Dynamic interactions between epithelial skin cells and a sensory cavity sculpt the growing olfactory orifice

  2025cites this paper
• Antitumoral Effects of Fungal Natural Products on Chronic Myeloid Leukemia Models: What Do We Know so Far?

  2025cites this paper
• Ensemble model for neoadjuvant chemotherapy response prediction and treatment sensitivity in TNBC based on DNA replication stress signatures

  2025cites this paper
• CAMK2B Impacts the Proliferation, Invasion, and Migration of Glioma Cells via the Ras/Raf/MEK/ERK Signaling Pathway

  2025cites this paper
• System analysis links SMARCD3 regulons to growth signaling and MEK inhibitor response in everolimus-resistant ER+ breast cancer cells

  2025cites this paper
• Analyzing the loss of nest related phenotype and revealing the operability of pancreatic ductal adenocarcinoma through electrochemical sensor content and scRNA seq

  2025cites this paper
• Anti-inflammatory effects and mechanisms of Podophyllum hexandrum rhizomes and fruits in a chronic pelvic inflammatory disease rat model.

  2025cites this paper
• Redefining the role of IL-18 in post-surgical recovery and sepsis: a key mediator of inflammation resolution

  2025cites this paper
• NRas Nanoclusters Mediate Crosstalk Between BRAF/ERK and PI3K/AKT Signaling in Melanoma Cells

  2025cites this paper
• Integrated network toxicology, molecular docking, molecular dynamics simulation, and experimental verification to elucidate the mechanism of hepatotoxicity and processing detoxification in Fructus Meliae Toosendan.

  2025cites this paper
• tRF‐30‐FP18LPMBQ4NK in Systemic Juvenile Idiopathic Arthritis: A Promising Diagnostic and Disease Activity Biomarker

  2025cites this paper
• Exploring MAPK and mTOR Pathways in Feline Thyroid Tumors

  2025cites this paper
• Multi-omics profile of exceptional long-term survivors of AJCC stage III triple-negative breast cancer.

  2025cites this paper
• Integrated Transcriptomic and Metabolomic Analysis Reveals the Induction of Anoikis in Renal Proximal Tubular Epithelial Cells by 2,6-Dichloro-1,4-benzoquinone.

  2025cites this paper
• A structure-based modelling approach identifies effective drug combinations for RAS-mutant acute myeloid leukemia

  2025cites this paper
• MT-125 inhibits non-muscle myosin IIA and IIB and prolongs survival in glioblastoma.

  2025cites this paper
• Polio virotherapy provokes MDA5 signaling and CD4+ T cell help to mediate cancer in situ vaccination

  2025cites this paper
• Unravelling molecular mechanism of oral squamous cell carcinoma and genetic landscape: an insight into disease complexity, available therapies, and future considerations

  2025influential citation
• A Novel Description of Immunodeficiency and Immune Dysregulation in a 14-Year-Old Girl with Noonan Syndrome 13

  2025cites this paper
• Chemical Compensation to Mechanical Loss in Cell Mechanosensation

  2025cites this paper
• Rosmarinic acid rich fraction from Orthosiphon aristatus (Blume) Miq. leaves induces apoptosis by inhibiting the rapamycin signalling pathway

  2025cites this paper
• PI3K/AKT signaling mediates stress-inducible amyloid formation through c-Myc.

  2025cites this paper
• Combined Omipalisib and MAPK Inhibition Suppress PDAC Growth

  2025cites this paper
• Targeting Signaling Excitability in Cervical and Pancreatic Cancer Cells Through Combined Inhibition of FAK and PI3K

  2025cites this paper
• A Phase Ia/b study of MEK1/2 inhibitor binimetinib with MET inhibitor crizotinib in patients with RAS mutant advanced colorectal cancer (MErCuRIC)

  2025cites this paper
• Antiproliferative and Antimigratory Effects of mTOR Inhibitors in Paediatric Low-grade Gliomas Models. A Comparison between Rapamycin and Sapanisertib

  2025cites this paper
• Targeting the phosphatidylinositol-3-kinase (PI3K) and mitogen activated protein kinase (MAPK) signalling pathways to enhance chemoradiotherapy in locally advanced rectal cancer.

  2025cites this paper
• Impact of polystyrene microplastics (PS-MPs) on the entire female mouse reproductive cycle: Assessing reproductive toxicity of microplastics through in vitro follicle culture.

  2025cites this paper
• Dopamine Receptor D3 Induces Transient, mTORC1-Dependent Autophagy That Becomes Persistent, AMPK-Mediated, and Neuroprotective in Experimental Models of Huntington’s Disease

  2025cites this paper
• Phytochemical intervention in BCRP-driven cancer drug resistance: A comprehensive review.

  2025cites this paper
• NOVEL INSIGHTS IN ADVANCED THYROID CARCINOMA: FROM MECHANISMS TO TREATMENTS: Molecular insights into the origin, biology, and treatment of anaplastic thyroid carcinoma

  2025cites this paper
• Thai Kratom extracts ameliorate MAFLD through multi-target mechanism in FFA-induced HepG2 cells

  2025cites this paper
• Loss of DNA replication fork protection by TIMELESS degradation supports oncogene-induced senescence.

  2025cites this paper
• Neobractatin and Trametinib Synergistically Induce Apoptosis and Gasdermin E‐Dependent Pyroptosis in Pancreatic Cancer Cells

  2025cites this paper
• ERK1/2 Signaling in Intrahepatic Cholangiocarcinoma: From Preclinical Advances to Therapeutic Strategies

  2025cites this paper
• Efficacy of Intranasal Esketamine in Treatment‐Resistant Depression: A Six‐Month Real‐World Follow‐Up Study of Depressive Symptoms, Hopelessness, and Suicide Risk

  2025cites this paper
• Unlocking the therapeutic potential of rigosertib as a selective therapy for ovarian cancer

  2025cites this paper
• Phytochemical modulation of mTOR signaling: emerging nanotechnology-driven therapeutics for rheumatoid arthritis management

  2025cites this paper
• Peptide inhibitors: Breaking cancer code.

  2025cites this paper
• Nitro-Substituted Benzylic Organochalcogenides as Anticancer Agents: Unravelling the Multifaceted Pathways to Combat Triple-Negative Breast Cancer.

  2025cites this paper
• Ribosome Biogenesis and Function in Cancer: From Mechanisms to Therapy

  2025cites this paper
• Comparative effects of standardized Centella asiatica extract (ECa 233) and its active compound mixture on proteomics and mitochondrial function

  2025cites this paper
• Research progress on the mechanisms of CSF3R mutations in leukemogenesis and treatment strategies

  2025cites this paper
• An exploration on the involvement of the methyltransferase like 3-m6A‑zinc finger MYM-type containing 1 axis in the progression of liver hepatocellular carcinoma.

  2025cites this paper
• TIMP-1 Modulation Correlates with KRAS Dependency and EMT Induction in NSCLC

  2025cites this paper
• The many ways to inhibit translation by Sorafenib in liver cancer cells

  2025cites this paper
• KRAS mutations promote PD-L1-mediated immune escape by ETV4 in lung adenocarcinoma

  2025cites this paper
• GLUT1 Expression Patterns in Verruciform Acanthotic Vulvar Squamous Intraepithelial Neoplasia, HPV-independent p53 Wild-Type Squamous Cell Carcinoma and Benign Vulvar Lesions.

  2025cites this paper
• Loss of Golga7 Suppresses Oncogenic Nras‐Driven Leukemogenesis without Detectable Toxicity in Adult Mice

  2025cites this paper